대웅제약069620
의료용 물질·의약품 · 공시 이벤트 54건
매출액
1.42조원
영업이익
1,479억원
부채비율
113.3%
영업이익률
10.4%
2024년 사업보고서(연결) 기준
이벤트 유형
공시 이력과 주가 반응
| 공시일 | 이벤트 | D+1 | D+5 | D+20 | 원문 |
|---|---|---|---|---|---|
| 2026.07.29 | 잠정실적(공정공시) | +2.7% | +2.0% | +2.3% | DART |
| 2026.06.26 | 단일판매·공급계약 | +11.0% | +23.5% | +19.6% | DART |
| 2026.05.12 | 잠정실적(공정공시) | -4.0% | -6.6% | -16.3% | DART |
| 2026.02.25 | 현금·현물배당 | -2.2% | -10.3% | -12.8% | DART |
| 2026.02.12 | 단일판매·공급계약 | -2.3% | +11.9% | -6.5% | DART |
| 2026.02.09 | 잠정실적(공정공시) | +6.0% | +2.7% | -0.9% | DART |
| 2026.02.09 | 손익구조 30% 변동 | +6.0% | +2.7% | -0.9% | DART |
| 2025.11.07 | 잠정실적(공정공시) | +8.6% | +24.4% | +31.3% | DART |
| 2025.07.31 | 잠정실적(공정공시) | -3.0% | -8.7% | -7.6% | DART |
| 2025.04.28 | 잠정실적(공정공시) | +5.0% | +9.5% | +11.2% | DART |
| 2025.02.25 | 현금·현물배당 | +3.7% | -1.5% | -5.9% | DART |
| 2025.02.14 | 단일판매·공급계약 | +3.6% | +0.4% | -8.3% | DART |
| 2025.02.10 | 잠정실적(공정공시) | -5.5% | -5.4% | -16.3% | DART |
| 2025.02.10 | 손익구조 30% 변동 | -5.5% | -5.4% | -16.3% | DART |
| 2024.12.23 | 단일판매·공급계약 | -0.7% | +0.7% | +9.4% | DART |
| 2024.10.30 | 잠정실적(공정공시) | +6.4% | +6.4% | -15.6% | DART |
| 2024.08.09 | 잠정실적(공정공시) | +0.3% | +12.6% | +8.6% | DART |
| 2024.04.29 | 잠정실적(공정공시) | -1.1% | -0.4% | -8.9% | DART |
| 2024.02.26 | 현금·현물배당 | -2.0% | -1.7% | +5.6% | DART |
| 2024.02.05 | 잠정실적(공정공시) | +1.9% | +6.9% | +1.3% | DART |
| 2024.02.05 | 손익구조 30% 변동 | +1.9% | +6.9% | +1.3% | DART |
| 2023.12.11 | 단일판매·공급계약 | +0.3% | -2.2% | +2.3% | DART |
| 2023.12.01 | 단일판매·공급계약 | -1.0% | +3.0% | +9.4% | DART |
| 2023.10.27 | 잠정실적(공정공시) | -0.7% | +0.6% | +7.9% | DART |
| 2023.07.27 | 잠정실적(공정공시) | +3.5% | +12.3% | +11.3% | DART |
| 2023.05.03 | 잠정실적(공정공시) | +3.7% | +1.6% | +3.4% | DART |
| 2023.03.08 | 현금·현물배당 | +0.9% | -6.8% | -4.4% | DART |
| 2023.03.08 | 자기주식처분 | +0.9% | -6.8% | -4.4% | DART |
| 2023.02.24 | 단일판매·공급계약 | -2.4% | -2.7% | -11.2% | DART |
| 2023.02.15 | 잠정실적(공정공시) | +0.5% | -2.1% | -13.8% | DART |
| 2023.02.15 | 손익구조 30% 변동 | +0.5% | -2.1% | -13.8% | DART |
| 2022.10.31 | 잠정실적(공정공시) | +1.6% | -2.2% | -8.4% | DART |
| 2022.07.28 | 잠정실적(공정공시) | -4.7% | -7.3% | -9.6% | DART |
| 2022.04.28 | 잠정실적(공정공시) | +4.3% | +1.7% | 0.0% | DART |
| 2022.03.08 | 현금·현물배당 | +2.4% | +5.5% | +3.3% | DART |
| 2022.02.15 | 손익구조 30% 변동 | +7.0% | +15.0% | +21.6% | DART |
| 2022.02.15 | 잠정실적(공정공시) | +7.0% | +15.0% | +21.6% | DART |
| 2021.10.27 | 잠정실적(공정공시) | +1.1% | +1.8% | -4.6% | DART |
| 2021.10.15 | 단일판매·공급계약 | +0.7% | 0.0% | -0.7% | DART |
| 2021.07.29 | 잠정실적(공정공시) | +1.8% | +6.5% | -3.9% | DART |
| 2021.05.06 | 잠정실적(공정공시) | +5.5% | +8.1% | +18.0% | DART |
| 2021.03.18 | 단일판매·공급계약 | +0.8% | -1.9% | +6.5% | DART |
| 2021.03.18 | 자기주식처분 | +0.8% | -1.9% | +6.5% | DART |
| 2021.03.11 | 현금·현물배당 | +1.2% | +6.1% | +4.9% | DART |
| 2021.02.15 | 손익구조 30% 변동 | -4.4% | +5.4% | -14.6% | DART |
| 2021.02.15 | 잠정실적(공정공시) | -4.4% | +5.4% | -14.6% | DART |
| 2020.11.04 | 잠정실적(공정공시) | +2.2% | -0.7% | +16.2% | DART |
| 2020.08.14 | 단일판매·공급계약 | -5.6% | +3.0% | -0.4% | DART |
| 2020.07.30 | 잠정실적(공정공시) | -1.8% | +20.5% | +0.9% | DART |
| 2020.05.07 | 잠정실적(공정공시) | 0.0% | -1.9% | +4.8% | DART |
| 2020.03.23 | 자기주식처분 | +8.3% | +21.9% | +57.6% | DART |
| 2020.02.27 | 현금·현물배당 | -3.2% | -6.9% | -26.4% | DART |
| 2020.02.19 | 손익구조 30% 변동 | -1.3% | -8.0% | -38.6% | DART |
| 2020.02.13 | 잠정실적(공정공시) | +2.1% | +0.8% | -28.2% | DART |
연도별 재무
| 연도 | 매출액 | 영업이익 | 당기순이익 | 자산총계 | 자본총계 |
|---|---|---|---|---|---|
| 2022 | 1.28조원 | 958억원 | 422억원 | 1.56조원 | 7,412억원 |
| 2023 | 1.38조원 | 1,226억원 | 1,200억원 | 1.77조원 | 9,123억원 |
| 2024 | 1.42조원 | 1,479억원 | 247억원 | 1.98조원 | 9,270억원 |